Stay updated on CPX-351 and Quizartinib in AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page
- Check4 days agoChange DetectedThe study record history shows an update on 2026-06-02 changing the status to Active, not recruiting and adding new sections for Contacts/Locations, Study Status, and Recruitment Status. This update is tracked under revision v3.5.5, replacing the previous v3.5.4 which listed Recruiting.SummaryDifference0.7%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedFooter revision label updated from v3.5.3 to v3.5.4, indicating a minor platform release. No study content or page functionality changes are introduced by this update.SummaryDifference0.1%

- Check39 days agoChange DetectedA new revision entry (version 20) was added to the Record History with a Study Status update dated 2026-04-21, and a subsequent 2026-04-24 entry records another Study Status change.SummaryDifference0.3%

- Check46 days agoChange DetectedThe page’s footer/test tooling label was updated from Revision v3.5.2 to v3.5.3, indicating a maintenance/version release rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page footer now shows Revision: v3.5.0 (replacing v3.4.3). The overall record history content remains unchanged.SummaryDifference0.1%

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.